Nestlé to invest in medical nutrition plant
Nestlé will invest in excess of AUS$17 million in a new ready-to-drink medical supplement manufactur…Nestlé will invest in excess of AUS$17 million in a new ready-to-drink medical supplement manufacturing facility in Australia.
A range of medical nutrition products will be made at the site in Tongala, Victoria for Nestlé Health Science, a fully owned subsidiary of Nestlé set up in January 2011. Nestlé’s medical nutrition products are designed to help manage health conditions such as diabetes, renal disorders and malnutrition.
The newly-built extension, which will create 30 jobs, will also produce tube-feeding liquid products for people who have been hospitalised and are unable to eat normal food.
The facility will produce about 7,000 tonnes of products each year, which will be distributed across the rest of Australia and to some other countries in the region.
“This significant investment by Nestlé Australia to extend its Tongala factory into a bigger production hub is a huge vote of confidence the company has in the region,” said Paul Bruhn, Nestlé Health Science’s regional business head for Asia, Oceania and Africa.
“The transformation to our factory creates enormous potential for growth as we develop and roll out new products for local and regional markets."
